Therefore, it is remarkable that a poorly immunogenic cancer model which did not respond to a complete knockout in FGL2 (Fgl2−/− mice) was able to survive significantly longer with the addition of an oncolytic virus to an FGL2-deficient background. This evidence concerns the gene FGL2 and cancer.